Prevention & Chronic Conditions


Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.


Antiarrhythmic Drug Therapy to Avoid ICD Shocks


Arrhythmia & Electrophysiology Review 2016;5(2):117–21

Pharmacological Tests in Atrial Fibrillation Ablation


Arrhythmia & Electrophysiology Review 2016;5(3):170–6

Atrial Fibrillation and Heart Failure: How Should We Manage Our Patients?


Arrhythmia & Electrophysiology Review 2016;5(3):162-3

Arrhythmogenic Right Ventricular Cardiomyopathy – Antiarrhythmic Therapy


Arrhythmia & Electrophysiology Review 2015; 4(2):86–9